Publication | Open Access
Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy
24
Citations
31
References
2019
Year
NK101 is a unique NK cell line bearing strong immunostimulatory potential and substantial scalability, providing an attractive source for adoptive cancer immunotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1